Susquehanna International Group, LLP Landec Corp \Ca\ Call Options Transaction History

Susquehanna International Group, LLP

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	N/A	7,800 Added 13.45%	65,800 $0
Q2 2024 Aug 15, 2024	SELL	N/A	-25,700 Reduced 30.7%	58,000 $0
Q1 2024 May 07, 2024	BUY	N/A	17,600 Added 26.63%	83,700 $0
Q4 2023 Feb 14, 2024	BUY	N/A	20,400 Added 44.64%	66,100 $0
Q3 2023 Nov 14, 2023	SELL	N/A	-23,300 Reduced 33.77%	45,700 $0
Q2 2023 Aug 11, 2023	BUY	N/A	69,000 New	69,000 $0
Q1 2018 May 15, 2018	SELL	$12.0 - $14.45 $34,800 - $41,905	-2,900 Reduced 17.16%	14,000 $183,000
Q3 2017 Nov 14, 2017	BUY	$11.95 - $13.35 $201,955 - $225,615	16,900	16,900 $219,000

20.4M

65.8K

14.1K

Ticker LNDC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 29,595,600
Description
Landec Corporation operates as a diversified health and wellness company. The company manufactures pharmaceutical-grade sodium hyaluronate (HA)-based biomaterials for primary use in the ophthalmic and orthopedic markets. It also provides product development services to its partners for HA-based, as well as non-HA based, aseptically formulated, a...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.